Literature DB >> 12958278

Chemically defined media for growth of Haemophilus influenzae strains.

Hannah N Coleman1, Dayle A Daines, Justin Jarisch, Arnold L Smith.   

Abstract

A chemically defined medium that supports the growth of both encapsulated and nontypeable Haemophilus influenzae strains in broth to densities that are >/= 10(9) CFU/ml or on agar plates is described. The mean generation time of a panel of clinical isolates was comparable to that in rich, chemically undefined media (brain-heart infusion broth supplemented with heme and beta-NAD).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958278      PMCID: PMC193788          DOI: 10.1128/JCM.41.9.4408-4410.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Defined medium for Haemophilus influenzae type B.

Authors:  H L WOLIN
Journal:  J Bacteriol       Date:  1963-01       Impact factor: 3.490

2.  Isolation and characterization of mutants of Haemophilus influenzae deficient in an adenosine 5'-triphosphate-dependent deoxyribonuclease activity.

Authors:  K W Wilcox; H O Smith
Journal:  J Bacteriol       Date:  1975-05       Impact factor: 3.490

3.  Fimbria-mediated enhanced attachment of nontypeable Haemophilus influenzae to respiratory syncytial virus-infected respiratory epithelial cells.

Authors:  Z Jiang; N Nagata; E Molina; L O Bakaletz; H Hawkins; J A Patel
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing.

Authors:  B W Catlin
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

5.  Defined medium for growth of Haemophilus influenzae.

Authors:  R M Herriott; E Y Meyer; M Vogt; M Modan
Journal:  J Bacteriol       Date:  1970-02       Impact factor: 3.490

6.  Simplified media for the growth of Haemophilus influenzae from clinical and normal flora sources.

Authors:  R D Klein; G H Luginbuhl
Journal:  J Gen Microbiol       Date:  1979-08

7.  High-molecular-weight proteins of nontypable Haemophilus influenzae mediate attachment to human epithelial cells.

Authors:  J W St Geme; S Falkow; S J Barenkamp
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

8.  A virulent nonencapsulated Haemophilus influenzae.

Authors:  V Nizet; K F Colina; J R Almquist; C E Rubens; A L Smith
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

9.  Repair of deoxyribonucleic acid in Haemophilus influenzae. I. X-ray sensitivity of ultraviolet-sensitive mutants and their behavior as hosts to ultraviolet-irradiated bacteriophage and transforming deoxyribonucleic acid.

Authors:  J K Setlow; D C Brown; M E Boling; A Mattingly; M P Gordon
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

10.  Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation.

Authors:  A L Smith; D H Smith; D R Averill; J Marino; E R Moxon
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

View more
  34 in total

1.  Biological roles of nontypeable Haemophilus influenzae type IV pilus proteins encoded by the pil and com operons.

Authors:  Michael D Carruthers; Erin N Tracy; Amanda C Dickson; Kara B Ganser; Robert S Munson; Lauren O Bakaletz
Journal:  J Bacteriol       Date:  2012-02-10       Impact factor: 3.490

2.  Comprehensive Proteomic and Metabolomic Signatures of Nontypeable Haemophilus influenzae-Induced Acute Otitis Media Reveal Bacterial Aerobic Respiration in an Immunosuppressed Environment.

Authors:  Alistair Harrison; Laura G Dubois; Lisa St John-Williams; M Arthur Moseley; Rachael L Hardison; Derek R Heimlich; Alexander Stoddard; Joseph E Kerschner; Sheryl S Justice; J Will Thompson; Kevin M Mason
Journal:  Mol Cell Proteomics       Date:  2015-12-28       Impact factor: 5.911

3.  Novel sialic acid transporter of Haemophilus influenzae.

Authors:  Simon Allen; Anthony Zaleski; Jason W Johnston; Bradford W Gibson; Michael A Apicella
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 4.  NAD+ utilization in Pasteurellaceae: simplification of a complex pathway.

Authors:  Gabriele Gerlach; Joachim Reidl
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

5.  Uptake of Sialic Acid by Nontypeable Haemophilus influenzae Increases Complement Resistance through Decreasing IgM-Dependent Complement Activation.

Authors:  Marjolein M P Oerlemans; Sam J Moons; Jurriaan J A Heming; Thomas J Boltje; Marien I de Jonge; Jeroen D Langereis
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

6.  Ferric uptake regulator and its role in the pathogenesis of nontypeable Haemophilus influenzae.

Authors:  Alistair Harrison; Estevan A Santana; Blake R Szelestey; David E Newsom; Peter White; Kevin M Mason
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

7.  Binding of human factor H to outer membrane protein P5 of non-typeable Haemophilus influenzae contributes to complement resistance.

Authors:  Jeroen D Langereis; Marien I de Jonge; Jeffrey N Weiser
Journal:  Mol Microbiol       Date:  2014-08-18       Impact factor: 3.501

8.  Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages.

Authors:  H J Metcalfe; S Lea; D Hughes; R Khalaf; K Abbott-Banner; D Singh
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

9.  Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria.

Authors:  Adam J Ratner; Jorge L Aguilar; Mikhail Shchepetov; Elena S Lysenko; Jeffrey N Weiser
Journal:  Cell Microbiol       Date:  2007-05       Impact factor: 3.715

10.  Expression of the Nontypeable Haemophilus influenzae Type IV Pilus Is Stimulated by Coculture with Host Respiratory Tract Epithelial Cells.

Authors:  Elaine M Mokrzan; Taylor J Johnson; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.